Chromatine/Épigénétique
Les inhibiteurs de la chromatine/épigénétique sont des composés qui modulent la structure et la fonction de la chromatine ou interfèrent avec les modifications épigénétiques, telles que la méthylation de l'ADN et la modification des histones. Ces inhibiteurs sont des outils essentiels pour étudier la régulation de l'expression génique et le rôle de l'épigénétique dans des maladies telles que le cancer, les troubles neurologiques et les anomalies du développement. En ciblant les processus épigénétiques, ces inhibiteurs peuvent modifier les schémas d'expression génique et offrir de nouvelles perspectives thérapeutiques. Chez CymitQuimica, nous offrons une large sélection d'inhibiteurs de la chromatine/épigénétique de haute qualité pour soutenir vos recherches en biologie moléculaire, génétique et épigénétique.
Sous-catégories appartenant à la catégorie "Chromatine/Épigénétique"
2612 produits trouvés pour "Chromatine/Épigénétique"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
KDM2/7-IN-1
CAS :KDM2/7-IN-1 is a selective histone demethylase inhibitor (IC50s: 0.2–>120 μM) that inhibits HeLa and KYSE-150 cell proliferation, epigenetic and cancer.Formule :C15H27NO4Degré de pureté :99.87%Couleur et forme :SolidMasse moléculaire :285.38BRM/BRG1 ATP Inhibitor-4
CAS :BRM/BRG1 ATP Inhibitor-4, a potent inhibitor of BRG1/BRM, is utilized in the research of cancers and BAF complex-related disorders.Formule :C25H32N6O3SCouleur et forme :SolidMasse moléculaire :496.62DPQ
CAS :DPQ inhibits PARP-1, aids in neuroprotection, restores ATP, and lessens neuronal injury from NMDA.
Formule :C18H26N2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :302.41PIM1-IN-6
CAS :PIM1-IN-6 (5h) inhibits PIM-1 (IC50: 0.60 μM) and is cytotoxic to HCT-116 (IC50: 1.51 μM) and MCF-7 cells (IC50: 15.2 μM).Formule :C21H18N6O4Couleur et forme :SolidMasse moléculaire :418.41SGC6870
CAS :SGC6870 is a novel potent, selective, and cell-active inhibitor of PRMT6 with IC50 of 77 ± 6 nM, being selective over all other PRMTs and 23 methyltransferases.Formule :C23H21BrN2O2SCouleur et forme :SolidMasse moléculaire :469.39DCE_42
CAS :DCE_42 is a novel EZH2 inhibitor, it also displays significant anti-proliferation activity against lymphoma cell lines.Formule :C22H19N9O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :473.51AMPK activator 4
CAS :Potent, selective AMPK activator 4 enhances glucose tolerance and insulin sensitivity without affecting mitochondrial complex I.Formule :C24H21ClN2O3Degré de pureté :99.97% - 99.99%Couleur et forme :SolidMasse moléculaire :420.89Ref: TM-T62238
1mg86,00€5mg173,00€10mg334,00€25mg563,00€50mg802,00€100mg1.099,00€500mg2.187,00€1mL*10mM (DMSO)203,00€Tankyrase-IN-4
Tankyrase-IN-4 is a potent inhibitor of tankyrase 1 (TNKS1), exhibiting an IC50 of 0.8 nM, and is utilized in cancer research.Formule :C25H24N6O5Couleur et forme :SolidMasse moléculaire :488.5DS-437
CAS :DS-437 is a dual PRMT5/7 inhibitor (IC50s: 6 μM). DS-437 also inhibits DNMT3A and DNMT3B (IC50s: 52 and 62 μM). DS-437 inhibits the methylation of FOXP3.Formule :C15H23N7O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :397.45KBH-A42
CAS :KBH-A42 is an inhibitor of histone deacetylase.Formule :C17H22N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :302.37MI-1
CAS :MI-1 inhibits Menin-MLL interaction with an IC 50 of 1.9 μM [1].Formule :C19H25N5S2Couleur et forme :SolidMasse moléculaire :387.57Piribedil dihydrochloride
CAS :dopamine agonistFormule :C16H20Cl2N4O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :371.26Dot1L-IN-7
CAS :Dot1L-IN-7 (compound 25), a potent DOT1L inhibitor with an IC50 of 1.0 μM, selectively kills MLL-AF9, sparing E2A-HLF cells.Formule :C23H27N9O2Couleur et forme :SolidMasse moléculaire :461.526-Methyl-5-azacytidine
CAS :6-Methyl-5-azacytidine is a potent DNMT inhibitor.Formule :C9H14N4O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :258.23PI3K/HDAC-IN-1
CAS :PI3K/HDAC-IN-1 is a potent PI3K and HDAC dual inhibitor(IC50s of 8.1 nM and 1.4 nM, respectively).
Formule :C22H25FN4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :428.46Tripartin
CAS :Tripartin specifically inhibits the histone H3 lysine 9 demethylase KDM4 in HeLa cells.Formule :C10H8Cl2O4Couleur et forme :SolidMasse moléculaire :263.07K00135
CAS :K00135 (IMIDAZOPYRIDAZIN 1) is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.Formule :C18H18N4ODegré de pureté :98.16%Couleur et forme :SolidMasse moléculaire :306.36BRD4 Inhibitor-19
CAS :BRD4 inhibitors -19 are BET inhibitors that act on BRD4-BD1 (IC50: 55 nM) and can be used to study multiple myeloma.Formule :C29H25N5O3Couleur et forme :SolidMasse moléculaire :491.54TK4g
CAS :TK4g, a potent JAK inhibitor, has IC50s of 12.61 nM (JAK2) & 15.80 nM (JAK3); promising for lymphoid diseases & leukemia research.Formule :C19H19N3O4SCouleur et forme :SolidMasse moléculaire :385.44LT052
CAS :LT052 is a BET BD1 inhibitor with anti-inflammatory activity. It mediates the BRD4/NF-κB/NLRP3 signaling inflammatory pathway.Formule :C22H19N5O4SDegré de pureté :98.82%Couleur et forme :SolidMasse moléculaire :449.48TyK2-IN-2
CAS :TyK2-IN-2 is a selective inhibitor of TYK2 (IC50s: 7 nM, 0.1 μM, and 0.05 μM for TYK2 JH2, IL-23, and IFNα).Formule :C16H18N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :310.35CPI703
CAS :CPI703 is a novel potent and specific CBP/EP300 bromodomain inhibitor.Formule :C17H22N4ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :298.38aPKC-I
CAS :aPKC-I specifically inhibits PKCζ/i, blocks VEGF effects, and prevents IR-induced permeability in cells and live models.Formule :C15H17NO4SCouleur et forme :SolidMasse moléculaire :307.36UNC2327
CAS :UNC2327 is a potent and selective inhibitor of protein arginine methyltransferase 3 (PRMT3) (IC50:230 nM).Formule :C14H17N5O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :319.38NAT2-IN-1
CAS :NAT2-IN-1 (APA) is a selective inhibitor of the drug metabolism enzyme N-acetyltransferase 2 (NAT2), capable of targeting and eliminating cells with slow NAT2Formule :C19H20N4O3Couleur et forme :SolidMasse moléculaire :352.39SC-10
CAS :SC-10 is a direct activator of PKC with potential antiproliferative activity, useful in leukemia research.Formule :C17H22ClNO2SDegré de pureté :99.24% - 99.58%Couleur et forme :SolidMasse moléculaire :339.88Tinostamustine HCl
CAS :Tinostamustine (EDO-S101) is an alkylating HDACi fusion molecule, enhancing potency and overcoming drug resistance.Formule :C19H29Cl3N4O2Couleur et forme :SolidMasse moléculaire :451.82Lorpucitinib
CAS :Lorpucitinib (JNJ-64251330) is a JAK kinase inhibitor used in the study of inflammatory and gastrointestinal diseases.Formule :C22H28N6O2Degré de pureté :99.72%Couleur et forme :SolidMasse moléculaire :408.5BAY1238097
CAS :BAY1238097 is a BET inhibitor with anticancer activity and antiproliferative activity for the study of advanced refractory malignancies.Formule :C25H33N5O3Degré de pureté :98.1% - 98.79%Couleur et forme :SolidMasse moléculaire :451.56Ref: TM-T12660L
1mg49,00€5mg101,00€10mg172,00€25mg355,00€50mg620,00€100mg1.044,00€200mg1.404,00€1mL*10mM (DMSO)113,00€CAY10721
CAS :CAY10721 inhibits SIRT3 (39% at 200 μM), linked to OSCC and breast cancer; lowers OSCC growth, enhances radio/chemo sensitivity.Formule :C18H13N3O3SCouleur et forme :SolidMasse moléculaire :351.38CMP-5 hydrochloride
CAS :CMP-5 hydrochloride: potent, selective PRMT5 inhibitor; inactive against PRMT1/4/7; blocks S2Me-H4R3 on histones.Formule :C21H22ClN3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :351.87CSV0C018875 Hydrochloride
CAS :CSV0C018875 Hydrochloride: Novel G9a inhibitor with low toxicity, effective in enzyme/cell assays, outperforms BIX-0129.Formule :C18H18Cl2N2OCouleur et forme :SolidMasse moléculaire :349.255BRD4884
CAS :BRD4884 is a highly selective and efficient HDAC1 and HDAC2 inhibitor that also inhibits HDAC3, used in research on neurological disorders.Formule :C18H19FN2O2Degré de pureté :99.19% - 99.21%Couleur et forme :SolidMasse moléculaire :314.35Dimethyl-bisphenol A
CAS :DMBPA inhibits HIF-1α, promotes its degradation by detaching Hsp90, and reduces Vegfa mRNA expression.Formule :C17H20O2Couleur et forme :SolidMasse moléculaire :256.34p32 Inhibitor M36
CAS :p32 inhibitor M36 is an inhibitor of p32 mitochondrial protein. It binds directly to p32 and inhibits the p32 association with LyP-1.Formule :C23H28N8O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :448.52HMS607P03
CAS :HMS607P03 is an activator of SIRT1 which induces autophagic cell death via the AMPK-mTOR-ULK complex and induces mitophagy by the SIRT1-PINK1-Parkin pathway.Formule :C26H19ClN4O3S2Couleur et forme :SolidMasse moléculaire :535.04CCT077791
CAS :CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.Formule :C9H5ClN2O3SDegré de pureté :98.60%Couleur et forme :SolidMasse moléculaire :256.675-Octyl-α-ketoglutarate
CAS :In addition to its role in the Krebs cycle, α-ketoglutarate (2-oxoglutarate) has roles as a substrate or modulator of enzymes.Formule :C13H22O5Couleur et forme :SolidMasse moléculaire :258.31MC4343
MC4343, a potent dual inhibitor targeting both EZH2 and histone deacetylase, presents promising potential for cancer research applications.Formule :C36H41N5O4Couleur et forme :SolidMasse moléculaire :607.74TK4b
CAS :TK4b, a JAK inhibitor, targets leukemia/lymphoid diseases, with IC50s: 18.42 nM (JAK3) & 19.40 nM (JAK2).Formule :C21H22N2O2Couleur et forme :SolidMasse moléculaire :334.41Bizine dihydrochloride
CAS :Bizine dihydrochloride is a potent LSD1 inhibitor in vitro, being selective versus monoamine oxidases A/B and the LSD1 homologue, LSD2.Formule :C18H25Cl2N3OCouleur et forme :SolidMasse moléculaire :370.32Cercosporamide
CAS :Cercosporamide is a ATP-competitive Pkc1 kinase inhibitor (IC50 <50 nM; Ki <7 nM). It also is a unique Mnk inhibitor.Formule :C16H13NO7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :331.28AMPK activator 6
CAS :AMPK activator 6 stimulates AMPK, lowers lipids in cells, and reduces serum TC, LDL-C, and TG. Useful for NAFLD and metabolic research.Formule :C25H28O5Couleur et forme :SolidMasse moléculaire :408.49HDAC ligand-1
CAS :HDAC ligand-1 is a synthetic precursor utilized in the production of PROTAC-based HDAC degraders [1].Formule :C7H8N2ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :136.15PRMT5:MEP50 PPI
PRMT5:MEP50 PPI inhibitor with anti-tumor and anti-proliferative effects on lung and prostate cancers.Formule :C24H22N4O4Couleur et forme :SolidMasse moléculaire :430.46HAT-IN-1
CAS :HAT-IN-1 is an inhibitor of HAT used in the research of cancer.Formule :C23H18BrF4N3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :556.3CAY10727
CAS :CAY10727 selectively inhibits PAD3 (15,600 M^-1min^-1) over PAD1, PAD2, and PAD4.Formule :C21H22Cl2N4O2Couleur et forme :SolidMasse moléculaire :433.33NL-103
CAS :NL-103, a dual-targeting compound, inhibits HDACs & Hh pathway, countering vismodegib-resistant Smo mutations.Formule :C26H27Cl2N5O4Couleur et forme :SolidMasse moléculaire :544.43EPZ033294
CAS :EPZ033294 has potential anticancer and antiproliferative activity.Formule :C20H22ClN7ODegré de pureté :99.95%Couleur et forme :SolidMasse moléculaire :411.89Furamidine
CAS :Furamidine is a PRMT1-selective, cell-permeable inhibitor (IC50: 9.4μM), also targeting TDP-1, and is an antiparasitic bisbenzamidine derivative.Formule :C18H16N4ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :304.35JJO-1
CAS :JJO-1 is a bi-quinoline activating all AMPK αβγ isoforms except γ3; it requires low ATP and is unaffected by γ mutations or β deletions.Formule :C19H13N3Couleur et forme :SolidMasse moléculaire :283.33MicroRNA-21-IN-2
CAS :MicroRNA-21-IN-2 is a potential miR-21 inhibitor with an AC50 value of 3.29 μM. MicroRNA-21-IN-2 can be used to study cancer.Formule :C17H15N3O3SDegré de pureté :99.45%Couleur et forme :SolidMasse moléculaire :341.38JFD00244
CAS :JFD00244 is an inhibitor of sirtuin 2 (SIRT2). It has an anti-tumor effect.Formule :C30H26N2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :478.54JAK-2/3-IN-2
CAS :JAK-2/3-IN-2 (Compound 3h) is a potent JAK2 & JAK3 inhibitor with IC50s of 23.85 nM (JAK2) & 18.9 nM (JAK3).Formule :C19H19ClN2OSCouleur et forme :SolidMasse moléculaire :358.89A2B57
CAS :A2B57 is a selective SIRT2 inhibitor.Formule :C22H19N5ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :369.42DM-NOFD
CAS :DM-NOFD is a cell penetrant prodrug of NOFD, which is a potent and selective inhibitor of an asparaginyl hydroxylase FIH (factor-inhibiting HIF).Formule :C13H15NO5Couleur et forme :SolidMasse moléculaire :265.26A2AAR/HDAC-IN-1
CAS :A2AAR/HDAC-IN-1 (compound 14c) is an orally active, balanced A2AAR/HDAC dual inhibitor of A2AAR (Ki: 163.5 nM), HDAC1 (IC50: 145.3 nM). effect.Formule :C24H21N7O2Couleur et forme :SolidMasse moléculaire :439.47ZL0516
CAS :ZL0516, a chromone-based oral BRD4 BD1 inhibitor, shows potent in vivo efficacy and good pharmacokinetics, suggesting use in treating inflammation.Formule :C27H34N2O6Couleur et forme :SolidMasse moléculaire :482.57MARK-IN-4
CAS :MARK-IN-4 inhibits microtubule kinase (MARK) effectively (IC50: 1 nM), a target for Alzheimer's therapy.Formule :C21H23N7OSCouleur et forme :SolidMasse moléculaire :421.52PARP1-IN-9
CAS :PARP1-IN-9, potent PARP1 inhibitor with 30.51 nM IC50, outperforms Olaparib in anticancer efficacy.Formule :C18H21N3O5Couleur et forme :SolidMasse moléculaire :359.38NCDM-32B
CAS :NCDM-32B, a novel potent and selective KDM4 inhibitor, impairs viability and transforms phenotypes of basal breast cancer.Formule :C15H30N2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :302.41dWIZ-1
CAS :dWIZ-1 ((rac)-dWIZ-1) is a potent WIZ molecular gel degrader tha induction of haemoglobin fetalis (HbF) in erythroblasts, sickle cell disease (SCD).Formule :C22H29N3O4Degré de pureté :92.87% - 92.87%Couleur et forme :SolidMasse moléculaire :399.48CAY10722
CAS :CAY10722 is a SIRT3 inhibitor, affecting metabolism and cancer cell survival; varying impacts on esophageal and breast cancer.Formule :C21H14Cl2N2O2Couleur et forme :SolidMasse moléculaire :397.25SAR156497
CAS :SAR156497: selective Aurora A/B/C inhibitor; IC50: 0.5 nM (A), 1 nM (B), 3 nM (C); good metabolic stability; anti-tumoral without genetic specificity.Formule :C27H24N4O4Couleur et forme :SolidMasse moléculaire :468.5MAT2A-IN-6
CAS :MAT2A-IN-6 inhibits MAT2A, may slow MTAP-deficient cancer cell growth, has research value in cancer.Formule :C18H13ClF3N3O3Couleur et forme :SolidMasse moléculaire :411.76MZ-242
CAS :MZ-242 is an effective and selective inhibitor of Sirt2.Formule :C24H27N7O3S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :525.65KDOAM-25
CAS :KDOAM-25, a potent KDM5 inhibitor, enhances H3K4 methylation, hampers MM1S cell growth; IC50: 71 nM (5A), 19 nM (5B), 69 nM (5C/D).Formule :C15H25N5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :307.39Aurora Kinases-IN-2
CAS :Aurora Kinases-IN-2 (12Aj) hinders Aurora A/B kinases (IC50: 90/152 nM), used in cancer studies.Formule :C22H18ClN5O3Couleur et forme :SolidMasse moléculaire :435.86CypD inhibitor C-9
CAS :CypD inhibitor C-9 is a CypD inhibitor, it attenuates mitochondrial and cellular perturbation insulted by Aß and calcium stress.Formule :C22H22N4O4S2Couleur et forme :SolidMasse moléculaire :470.564-iodo-SAHA
CAS :4-Iodo-SAHA (1k), an oral HDAC inhibitor for cancer research, has EC50s from 0.12 to 1.3 μM across various cell lines.Formule :C14H19IN2O3Couleur et forme :SolidMasse moléculaire :390.22GW-841819X
CAS :GW841819X: (+)-JQ1 analogue, BET bromodomain inhibitor, active in vivo against various cancers.Formule :C25H21N5O2Couleur et forme :SolidMasse moléculaire :423.47JAK-IN-20
CAS :JAK-IN-20: potent oral JAK1,2,3 inhibitor with IC50s 7, 5, 14 nM respectively, good pharmacokinetics, anti-inflammatory in vivo.Formule :C28H30FN7O2Couleur et forme :SolidMasse moléculaire :515.58Peficitinib hydrochloride
CAS :Peficitinib HCl (ASP015K) is an oral JAK inhibitor with IC50s: JAK1 (3.9 nM), JAK2 (5.0 nM), JAK3 (0.7 nM), Tyk2 (4.8 nM).Formule :C18H23ClN4O2Couleur et forme :SolidMasse moléculaire :362.86HOI-07
CAS :HOI-07 is a specific Aurora B inhibitor.Formule :C19H13NO4Couleur et forme :SolidMasse moléculaire :319.31Sirt2-IN-6
CAS :Sirt2-IN-6 is a potent and selective inhibitor of SIRT2 (IC50: 0.815 μM) and can be used to study cancer.Formule :C26H26N6O3SCouleur et forme :SolidMasse moléculaire :502.59ZYJ-25e
CAS :ZYJ-25e is an oral histone deacetylase inhibitor (HDACi) with potent antitumor activities.Formule :C30H40N4O8Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :584.66SPV106
CAS :SPV106 is a ligand of lysine acetyltransferases (KATs).Formule :C22H40O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :368.55BIX-01338 hydrate
CAS :BIX-01338 hydrate is an inhibitor of histone lysine methyltransferase.Formule :C32H26F3N3O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :621.56Piribedil Maleate
CAS :Piribedil Maleate is a direct agonist of dopamine that acts by showing selectivity for the D3 subtype.Formule :C20H22N4O6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :414.41AC430
CAS :AC430, a specific JAK2 inhibitor for cancer and autoimmune therapy, excels in preclinical trials with low doses. Developed by Ambit.Formule :C19H16FN5OCouleur et forme :SolidMasse moléculaire :349.36BAY-6035-R-isomer
CAS :BAY-6035 is an inhibitor of the methylation of MEKK2 peptide.Formule :C22H28N4O3Couleur et forme :SolidMasse moléculaire :396.48TFMB-(S)-2-HG
CAS :TFMB-(S)-2-HG (TFMB S 2 HG) is a highly effective inhibitor of TET2, the 5'-methylcytosine hydroxylase.Formule :C13H11F3O4Degré de pureté :98.07%Couleur et forme :SolidMasse moléculaire :288.22Ref: TM-T24871
2mg34,00€5mg50,00€10mg79,00€25mg146,00€50mg227,00€100mg339,00€500mg713,00€1mL*10mM (DMSO)49,00€HDAC3 Inhibitor
CAS :HDAC3 inhibitor: allosteric, Ki=0.16 nM, favors HDAC3 over HDAC1/2, targets specific leukemia cells, EC50=36.37-151.7 nM.Formule :C20H23N3O2Couleur et forme :SolidMasse moléculaire :337.42Dot1L-IN-2
CAS :Dot1l-in-2 is an effective, selective and oral bioutilization inhibitor of histone methyltransferase Dot1L, with IC50 and Ki of 0.4 nM and 0.08 nM, respectivelyFormule :C27H24N8ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :476.53OTS186935
CAS :OTS186935 is a inhibitor of protein methyltransferase SUV39H2(IC50 of 6.49 nM).Formule :C25H26ClN5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :463.96PRMT5-IN-C17
CAS :PRMT5-IN-C17 is a novel potent, selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor.Formule :C18H17N3O4SCouleur et forme :SolidMasse moléculaire :371.41MIV-6
CAS :MIV-6 is an inhibitor of the menin-mixed lineage leukemia interaction.Formule :C27H35N3OCouleur et forme :SolidMasse moléculaire :417.595WKS
CAS :5WKS, or ZINC97756584, is a G9a inhibitor targeting H3K9me2 for gene silencing research in autoimmune diseases and tumors.Formule :C24H36ClN5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :462.03CL67
CAS :CL67 is a hypoxia-inducible factor pathway inhibitor. It acts by binding to a G-quadruplex higher-order structure in the HIF promoter sequence in vitro.Formule :C38H42N10O2Couleur et forme :SolidMasse moléculaire :670.81SRI-42127
CAS :SRI-42127 is a novel small molecule inhibitor of the RNA regulatory factor HuR that inhibits tumor growth and reduces neuropathic pain following nerve injury.Formule :C19H20N6ODegré de pureté :99.66%Couleur et forme :SolidMasse moléculaire :348.4PDAT
CAS :PDAT is a noncompetitive Indolethylamine N-methyltransferase inhibitor.Formule :C15H23N3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :245.36TM6008
CAS :TM6008 is an inhibitor of prolyl hydroxylase that protects against cell death after hypoxia.Formule :C21H17N5O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :387.39CTX-0124143
CAS :CTX-0124143 is a histone acetyltransferase inhibitor with an IC50 value of 1.0 μM for KAT6A.CTX-0124143 can be used to study cellular senescence.Formule :C17H13FN2O3SDegré de pureté :98.24%Couleur et forme :SolidMasse moléculaire :344.36MAT2A inhibitor 3
CAS :MAT2A inhibitor 3 can be used in the cancer research.Formule :C16H14ClN3OCouleur et forme :SolidMasse moléculaire :299.75JAK3i
CAS :JAK3i selectively inhibits JAK3 kinase, targeting the second, vital wave of STAT5 phosphorylation for T cell growth.Formule :C18H15FN4O3Degré de pureté :98.61% - 99.81%Couleur et forme :SolidMasse moléculaire :354.34SKF 91488 dihydrochloride
CAS :histamine N-methyltransferase inhibitorFormule :C7H19Cl2N3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :248.22IHCH-3064
CAS :IHCH-3064: dual-action cancer immunotherapy, A2AR affinity (Ki 2.2 nM), selective HDAC1 inhibitor (IC50 80.2 nM).Formule :C25H21N9O2Couleur et forme :SolidMasse moléculaire :479.49I-BET151 dihydrochloride
CAS :I-BET 151 dihydrochloride is a BET bromodomain inhibitor that prevents BET from recruiting to chromatin.Formule :C23H23Cl2N5O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :488.37Vibsanin A
CAS :Vibsanin A, an activator of protein kinase C (PKC) and an inhibitor of HSP90, demonstrates anti-proliferative effects on human cancer cell lines.Formule :C25H38O4Couleur et forme :SolidMasse moléculaire :402.57HDAC6-IN-5
CAS :HDAC6-IN-5 (11b), potent HDAC6 blocker, crosses BBB, IC50: 0.025μM, hinders Aβ1-42/AChE aggregation, boosts neurites, low toxicity.Formule :C20H14BrN3O2Couleur et forme :SolidMasse moléculaire :408.25
